Hélène Pelicano

12.2k total citations · 5 hit papers
59 papers, 10.1k citations indexed

About

Hélène Pelicano is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Hélène Pelicano has authored 59 papers receiving a total of 10.1k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Molecular Biology, 18 papers in Cancer Research and 13 papers in Oncology. Recurrent topics in Hélène Pelicano's work include Cancer, Hypoxia, and Metabolism (11 papers), Chronic Lymphocytic Leukemia Research (10 papers) and Mitochondrial Function and Pathology (9 papers). Hélène Pelicano is often cited by papers focused on Cancer, Hypoxia, and Metabolism (11 papers), Chronic Lymphocytic Leukemia Research (10 papers) and Mitochondrial Function and Pathology (9 papers). Hélène Pelicano collaborates with scholars based in United States, China and Netherlands. Hélène Pelicano's co-authors include Peng Huang, Dennis Carney, Rui‐Hua Xu, Jinsong Liu, Ping Huang, Daniel Martín, Michael J. Keating, Yan Zhou, Loning Fu and Cheng Chi Lee and has published in prestigious journals such as Cell, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Hélène Pelicano

59 papers receiving 9.9k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

ROS stress in cancer cells and therapeutic implications

2004 1.7k citations Hélène Pelicano, Dennis Carney et al. Drug Resistance Updates profile →
Glycolysis inhibition for anticancer treatment

2006 1.2k citations Hélène Pelicano, Rui‐Hua Xu et al. profile →
The Circadian Gene Period2 Plays an Important Role in Tumor Suppression and DNA Damage Response In Vivo

2002 1.0k citations Loning Fu, Hélène Pelicano et al. Cell profile →
Selective killing of oncogenically transformed cells through a ROS-mediated mechanism by β-phenylethyl isothiocyanate

2006 903 citations Dunyaporn Trachootham, Yan Zhou et al. Cancer Cell profile →
Inhibition of Glycolysis in Cancer Cells: A Novel Strategy to Overcome Drug Resistance Associated with Mitochondrial Respiratory Defect and Hypoxia

2005 699 citations Rui‐Hua Xu, Hélène Pelicano et al. Cancer Research profile →

Peers

Countries citing papers authored by Hélène Pelicano

Since Specialization

Citations

This map shows the geographic impact of Hélène Pelicano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hélène Pelicano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hélène Pelicano more than expected).

Fields of papers citing papers by Hélène Pelicano

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hélène Pelicano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hélène Pelicano. The network helps show where Hélène Pelicano may publish in the future.

Co-authorship network of co-authors of Hélène Pelicano

This figure shows the co-authorship network connecting the top 25 collaborators of Hélène Pelicano. A scholar is included among the top collaborators of Hélène Pelicano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hélène Pelicano. Hélène Pelicano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Aberrant FGFR Tyrosine Kinase Signaling Enhances the Warburg Effect by Reprogramming LDH Isoform Expression and Activity in Prostate Cancer 2018 ·Cancer Research ·Junchen Liu, Guo Chen, Zezhen Liu, Shaoyou Liu, Zhiduan Cai, Pan You, Yuepeng Ke, Li Lai, Yun Huang, Hongchang Gao, Liangcai Zhao, Hélène Pelicano, Peng Huang, Wallace L. McKeehan, Chin‐Lee Wu, Cong Wang, Weide Zhong, Fen Wang	88
2	Targeting the autophagy in bone marrow stromal cells overcomes resistance to vorinostat in chronic lymphocytic leukemia 2018 ·OncoTargets and Therapy ·Lu Ding, Wan Zhang, Lili Yang, Hélène Pelicano, (unknown), Ran Yin, Ruibin Huang, (unknown)	19
3	Alterations of mitochondrial biogenesis in chronic lymphocytic leukemia cells with loss of p53 2016 ·Mitochondrion ·Marcia A. Ogasawara, Jinyun Liu, Hélène Pelicano, Naima Hammoudi, Carlo M. Croce, Michael J. Keating, Peng Huang	13
4	Effective elimination of chronic lymphocytic leukemia cells in the stromal microenvironment by a novel drug combination strategy using redox-mediated mechanisms 2015 ·Molecular Medicine Reports ·Wan Zhang, Hélène Pelicano, Ran Yin, (unknown), Tong Wen, Lu Ding, Ruibin Huang	8
5	Mitochondrial dysfunction in some triple-negative breast cancer cell lines: role of mTOR pathway and therapeutic potential 2014 ·Breast Cancer Research ·Hélène Pelicano, Wan Zhang, Jinyun Liu, Naima Hammoudi, (unknown), Rui‐Hua Xu, Lajos Pusztai, Peng Huang	159
6	Identification of MicroRNA-214 as a negative regulator of colorectal cancer liver metastasis by way of regulation of fibroblast growth factor receptor 1 expression 2014 ·Hepatology ·Dong-liang Chen, Zhi-qiang Wang, Zhao-Lei Zeng, Wen-jing Wu, Dong-sheng Zhang, Hui Luo, Feng Wang, Miao‐Zhen Qiu, De‐Shen Wang, Chao Ren, Feng‐Hua Wang, (unknown), Hélène Pelicano, Peng Huang, Yuhong Li, Rui‐Hua Xu	109
7	Novel Role of NOX in Supporting Aerobic Glycolysis in Cancer Cells with Mitochondrial Dysfunction and as a Potential Target for Cancer Therapy 2012 ·PLoS Biology ·Weiqin Lu, Yumin Hu, Gang Chen, Chen Zhao, Hui Zhang, Feng Wang, Feng Li, Hélène Pelicano, Hua Wang, Michael J. Keating, Jinsong Liu, Wallace L. McKeehan, Huamin Wang, Yongde Luo, Peng Huang	125
8	Stromal control of cystine metabolism promotes cancer cell survival in chronic lymphocytic leukaemia 2012 ·Nature Cell Biology ·Wan Zhang, Dunyaporn Trachootham, Jinyun Liu, Gang Chen, Hélène Pelicano, Celia Garcı́a-Prieto, Weiqin Lu, Jan A. Burger, Carlo M. Croce, William Plunkett, Michael J. Keating, Peng Huang	280
9	K-rasG12V transformation leads to mitochondrial dysfunction and a metabolic switch from oxidative phosphorylation to glycolysis 2011 ·Cell Research ·Yumin Hu, Weiqin Lu, Gang Chen, Peng Wang, Zhao Chen, Yan Zhou, Marcia A. Ogasawara, Dunyaporn Trachootham, Feng Li, Hélène Pelicano, Paul J. Chiao, Michael J. Keating, Guillermo Garcia‐Manero, Peng Huang	245
10	Cancer Metabolism: Is Glutamine Sweeter than Glucose? 2010 ·Cancer Cell ·Weiqin Lu, Hélène Pelicano, Peng Huang	113
11	Mitochondrial Dysfunction and Reactive Oxygen Species Imbalance Promote Breast Cancer Cell Motility through a CXCL14-Mediated Mechanism 2009 ·Cancer Research ·Hélène Pelicano, Weiqin Lu, Yan Zhou, Wan Zhang, Zhao Chen, Yumin Hu, Peng Huang	154
12	Selective killing of oncogenically transformed cells through a ROS-mediated mechanism by β-phenylethyl isothiocyanate breakdown → 2006 ·Cancer Cell ·Dunyaporn Trachootham, Yan Zhou, Hui Zhang, Yusuke Demizu, Chen Zhao, Hélène Pelicano, Paul J. Chiao, Geetha Achanta, Ralph B. Arlinghaus, Jinsong Liu, Peng Huang	903
13	Selective killing of oncogenic transformed cells through ROS-mediated mechanism by β-phenylethyl isothiocyanates 2006 ·Cancer Research ·Dunyaporn Trachootham, Yan Zhou, Hélène Pelicano, Paul J. Chiao, Jinsong Liu, Peng Huang	2
14	Inducible expression of dominant negative DNA polymerase gamma(POLGdn) in human cells: characterizations and applications 2006 ·Cancer Research ·Weiqin Lu, Feng Li, Hélène Pelicano, (unknown), Geetha Achanta, Hui Zhang, Peng Huang	1
15	A Novel Mechanism of Action of Methyl-2-cyano-3,12 Dioxoolean-1,9 Diene-28-oate: Direct Permeabilization of the Inner Mitochondrial Membrane to Inhibit Electron Transport and Induce Apoptosis 2006 ·Molecular Pharmacology ·Ismael Samudio, Marina Konopleva, Hélène Pelicano, Peng Huang, Olga Frolova, William G. Bornmann, (unknown), Randall Evans, Rooha Contractor, Michael Andreeff	49
16	OSW-1: a Natural Compound With Potent Anticancer Activity and a Novel Mechanism of Action 2005 ·JNCI Journal of the National Cancer Institute ·Yan Zhou, Celia Garcı́a-Prieto, Dennis Carney, Rui‐Hua Xu, Hélène Pelicano, Ying Kang, Wensheng Yu, (unknown), Seiji Kondo, Jinsong Liu, David Harris, Zeev Estrov, Michael J. Keating, Zhendong Jin, Peng Huang	84
17	Novel role of p53 in maintaining mitochondrial genetic stability through interaction with DNA Pol γ 2005 ·The EMBO Journal ·Geetha Achanta, Ryohei Sasaki, Feng Li, Jennifer S. Carew, Weiqin Lu, Hélène Pelicano, Michael J. Keating, Peng Huang	229
18	ROS stress in cancer cells and therapeutic implications breakdown → 2004 ·Drug Resistance Updates ·Hélène Pelicano, Dennis Carney, Peng Huang	1675
19	The Circadian Gene Period2 Plays an Important Role in Tumor Suppression and DNA-Damage Response In Vivo 2002 ·Cell ·Loning Fu, Hélène Pelicano, Jinsong Liu, Peng Huang, Cheng Chi Lee	57
20	Excision of β-L- and β-D-Nucleotide Analogs From DNA by p53 Protein 2000 ·Nucleosides Nucleotides & Nucleic Acids ·Marina K. Kukhanova, (unknown), Hélène Pelicano, (unknown)	8

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact